Everolimus - Wikipedia
WEBEverolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants [10] and as a targeted therapy in the treatment of renal cell cancer and other tumours.
FDA approves new indication for Novartis drug Afinitor
WEBFeb 26, 2016 · Afinitor® (everolimus) tablets is now approved by the United States (US) Food and Drug Administration (FDA) for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic.
WEBAFINITOR is indicated for the treatment of adult patients with progressive, well-differentiated, non-functional NET of gastrointestinal (GI) or lung origin with unresectable, locally advanced or metastatic disease.
Afinitor: 7 things you should know - Drugs.com
WEBMay 23, 2024 · Afinitor is a brand (trade) name for everolimus which is a targeted medicine that may be used to treat various cancers. Afinitor is called an mTOR inhibitor. mTOR stands for mammalian target of rapamycin, and it is a type of protein in the body called a kinase that helps both healthy cells and cancerous cells get the energy they need.
Afinitor Pill Images - What does Afinitor look like? - Drugs.com
WEBView images of Afinitor and identify pills by imprint code, shape and color with the Drugs.com Pill Identifier.
Afinitor: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBApr 22, 2024 · Afinitor is used to treat certain types of kidney cancer, breast cancer, or brain tumor. It is also used to treat certain types of advanced or progressive tumors of the stomach, intestines, or pancreas.
Afinitor (everolimus): Side effects, cost, uses, and more
WEBDec 30, 2021 · Afinitor (everolimus) is a brand-name prescription drug used to treat certain types of cancers, tumors, and seizures. Learn about side effects, cost, and more.
Afinitor: Side Effects, Cost, Uses, and More - Healthline
WEBMar 14, 2022 · Learn about side effects, uses, and more for Afinitor (everolimus), which is a prescription drug that treats certain kinds of cancer, tumors, and seizure disorders.
Afinitor - European Medicines Agency (EMA)
WEBAfinitor is indicated for the treatment of hormone-receptor-positive, HER2/neu-negative advanced breast cancer, in combination with exemestane, in post-menopausal women without symptomatic visceral disease after recurrence or progression following a non-steroidal aromatase inhibitor.
WEBAfinitor is indicated for the treatment of: Hormone receptor-positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non-steroidal aromatase inhibitor.
- Some results have been removed